Developer of Alzheimer’s drug Exelon at Hebrew University’s School of Pharmacy: Israel Prize in Medicine awarded to Prof. Marta Weinstock-Rosin

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Developer of Alzheimer’s drug Exelon at Hebrew University’s School of Pharmacy: Israel Prize in Medicine awarded to Prof. Marta Weinstock-Rosin

Reporter: Aviva Lev-Ari, PhD, RN

Israel Prize in Medicine awarded to Prof. Marta Weinstock-Rosin, developer of Alzheimer’s drug

March 2, 2014

Developed blockbuster drug Exelon at Hebrew University’s School of Pharmacy

Jerusalem — Israel’s Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to The Hebrew University of Jerusalem’s Professor Marta Weinstock-Rosin. A professor emeritus at The Hebrew University’s School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Prof. Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer’s and Parkinson’s disease.

Prof. Weinstock-Rosin is married with four children and 20 grandchildren. She became Professor Marta Weinstock-Rosina professor at The Hebrew University in 1981 and head of its School of Pharmacy in 1983…

View original post 217 more words

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s